ArticleFrontiers in endocrinology2026
Ramadan fasting practices and acute complications among Arab children, adolescents, and young adults with diabetes: a cross-sectional survey.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Fasting during Ramadan poses specific challenges for children and adolescents with diabetes and may adversely affect glycemic control and the risk of acute complications. Data on the safety of Ramadan fasting among Arab youth with diabetes and adherence to guideline-based care remain limited. This study aimed to evaluate the experiences of Ramadan fasting among Arab children, adolescents, and youths with diabetes. Methods: In this cross-sectional study, we used an expert-reviewed and pilot-tested questionnaire distributed through social media to recruit a non-probabilistic online convenience sample of children, adolescents, and young adults with diabetes across Arab countries. All demographic, clinical, counseling, and fasting-related outcomes were self-reported. Results: In total, 242 (53.7% female) patients participated in this study. The most common age group was 13-17 years (50.8%), and 95.9% of the patients had type 1 diabetes. Before Ramadan, 11.5% reported diabetic ketoacidosis (DKA), 5.0% reported severe hypoglycemia during the previous 3 months, and 26.0% had hypoglycemia unawareness. Nearly half (45.5%) of the participants reported being permitted to fast by their physicians. During Ramadan, DKA and severe hypoglycemia occurred in 6.2% and 2.5% of the patients, respectively. The median number of completed fasting days was 22 (range 0-30). Older patients (aged 13-25 years) were more likely to be allowed to fast (p = 0.033) and complete more fasting days (p < 0.001). In multivariate regression, older age independently predicted fasting allowance (AOR = 1.951, 95% CI: 1.132 - 3.363, p = 0.016). Multiple daily injections decreased the likelihood of being allowed to fast (AOR = 0.444, 95% CI: 0.230 - 0.860, p = 0.016). The most common cause of fasting interruption was hypoglycemia (67.4%), followed by hyperglycemia (24.8%). A weak positive correlation was observed between pre-Ramadan counseling scores and the number of completed fasting days (Spearman's rho = 0.144; p = 0.025). Conclusion: Almost half of the participating Arab children, adolescents, and young adults with diabetes reported being permitted to fast during Ramadan. Older patients were more likely to be permitted to fast and completed more fasting days, and insulin pump users were more likely to be permitted to fast than those on multiple daily injections. A weak positive association was observed between counseling scores and the number of completed fasting days.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.